Helicobacter pylori and non-malignant diseases

Helicobacter

Volumn 13, Issue SUPPL.1, 2008, Pages 23-27

  Shirin, Haim ^b   Leja, Marcis ^c   Niv, Yaron ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c RIGA EAST UNIVERSITY HOSPITAL   (Latvia)

Author keywords

GERD; Helicobacter pylori; Nonulcer dyspepsia; NSAIDs; Peptic ulcer disease

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 2 INHIBITOR; INDOMETACIN; MELATONIN; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PROTON PUMP INHIBITOR;

ADENOCARCINOMA; ARTICLE; BARRETT ESOPHAGUS; CHRONIC GASTRITIS; DUODENUM DISEASE; DYSPEPSIA; ERADICATION THERAPY; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; LIVER CIRRHOSIS; MORTALITY; NONHUMAN; PATHOGENESIS; PEPTIC ULCER; PEPTIC ULCER BLEEDING; PREVALENCE; PRIORITY JOURNAL; STOMACH CANCER; STOMACH MUCOSA; UREMIA;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DYSPEPSIA; GASTROINTESTINAL DISEASES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS;

BACTERIA (MICROORGANISMS); HELICOBACTER PYLORI;

EID: 49249105301     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2008.00635.x     Document Type: Article

References (32)

1. Sonnenberg A. Time trends of ulcer mortality in Europe. Gastroenterology 2007 132 : 2320 7.
2. Sonnenberg A. Time trends of ulcer mortality in non-European countries. Am J Gastroenterol 2007 102 : 1101 7.
3. Gisbert JP, Calvet X, Feu F, et al. Eradication of Helicobacter pylori for the prevention of peptic ulcer rebleeding. Helicobacter 2007 12 : 279 86.
4. Nagai S, Mimuro H, Yamada T, Baba Y, Moro K, Nochi T, Kiyono H, Suzuki T, Sasakawa C, Koyasu S. Role of Peyer's patches in the induction of Helicobacter pylori-induced gastritis. Proc Natl Acad Sci USA 2007 104 : 8971 6.
5. Harris PR, Wright SW, Serrano C, et al. Helicobacter pylori gastritis in children is associated with a regulatory T-cell response. Gastroenterology 2008 134 : 491 9.
6. Lee CW, Lee CW, Rao VP, Rogers AB, Ge Z, Erdman SE, Whary MT, Fox JG. Wild-type and interleukin-10-deficient regulatory T cells reduce effector T-cell-mediated gastroduodenitis in Rag2-/- mice, but only wild-type regulatory T cells suppress Helicobacter pylori gastritis. Infect Immun 2007 75 : 2699 707.
7. Wilschanski M, Schlesinger Y, Faber J, Rudensky B, Ohnona FS, Freier S, Rahman E, Refael S, Halle D. Combination of Helicobacter pylori strain and tumor necrosis factor-alpha polymorphism of the host increases the risk of peptic ulcer disease in children. J Pediatr Gastroenterol Nutr 2007 45 : 199 203.
8. Arisawa T, Tahara T, Shibata T, et al. Association between genetic polymorphisms in the cyclooxygenase-1 gene promoter and peptic ulcers in Japan. Int J Mol Med 2007 20 : 373 8.
9. Pietroiusti A, Forlini A, Magrini A, Galante A, Bergamaschi A. Isolated H. pylori duodenal colonization and idiopathic duodenal ulcers. Am J Gastroenterol 2008 103 : 55 61.
10. Arachchi HS, Kalra V, Lal B, et al. Prevalence of duodenal ulcer-promoting gene (dupA) of Helicobacter pylori in patients with duodenal ulcer in North Indian population. Helicobacter 2007 12 : 591 7.
11. Argent RH, Burette A, Miendje Deyi VY, Atherton JC. The presence of dupA in Helicobacter pylori is not significantly associated with duodenal ulceration in Belgium, South Africa, China, or North America. Clin Infect Dis 2007 45 : 1204 6.
12. Tzathas C, Triantafyllou K, Mallas E, Triantafyllou G, Ladas SD. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study. J Clin Gastroenterol 2008 42 : 744 9.
13. Tseng GY, Lin HJ, Fang CT, Yang HB, Tseng GC, Wang PC, Hung TL, Deng YC, Cheng YT, Huang CH. Recurrence of peptic ulcer in uraemic and non-uraemic patients after Helicobacter pylori eradication: a 2-year study. Aliment Pharmacol Ther 2007 26 : 925 33.
14. Love JW. Peptic ulceration may be a hormonal deficiency disease. Med Hypotheses 2008 70 : 1103 7.
15. Kinoshita Y. Lifestyle-related diseases and Helicobacter pylori infection. Intern Med 2007 46 : 105 6.
16. Koike T, Ohara S, Inomata Y, Abe Y, Iijima K, Shimosegawa T. The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with gastroesophageal adenocarcinoma in Japan. Inflammopharmacology 2007 15 : 61 4.
17. Sotoudeh M, Derakhshan MH, Abedi-Ardakani B, Nouraie M, Yazdanhod A, Tavangar SM, Mikaeli J, Merat S, Malekzadeh R. Critical role of Helicobacter pylori in the pattern of gastritis and carditis in residents of an area with high prevalence of gastric cardia cancer. Dig Dis Sci 2008 53 : 27 33.
18. Kim N, Lee SW, Cho SI, et al. The prevalence of and risk factors for erosive oesophagitis and non-erosive reflux disease: a nationwide multicentre prospective study in Korea. Aliment Pharmacol Ther 2008 27 : 173 85.
19. Corley DA, Kubo A, Levin TR, et al. Helicobacter pylori infection and the risk of Barrett's oesophagus: a community-based study. Gut 2008 57 : 727 33.
20. Anderson LA, Murphy SJ, Johnston BT, et al. Relationship between Helicobacter pylori infection and gastric atrophy and the stages of the oesophageal inflammation, metaplasia, adenocarcinoma sequence: results from the FINBAR case-control study. Gut 2008 57 : 734 9.
21. Ramus JR, Gatenby PAC, Caygill CPJ, Watson A. Helicobacter pylori infection and severity of reflux-induced esophageal disease in a cohort of patients with columnar-lined esophagus. Dig Dis Sci 2007 52 : 2821 5.
22. McColl KLM. Helicobacter pylori and esophageal cancer - not always protective. Gut 2007 56 : 457 9.
23. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007 56 : 772 81.
24. Ford AC, Forman D, Bailey AG, Axon AT, Moayyedi P. Initial poor quality of life and new onset of dyspepsia: results from a longitudinal 10-year follow-up study. Gut 2007 56 : 321 7.
25. Ford AC, Forman D, Nathan J, Crocombe WD, Axon AT, Moayyedi P. Clinical trial: knowledge of negative Helicobacter pylori status reduces subsequent dyspepsia-related resource use. Aliment Pharmacol Ther 2007 26 : 1267 75.
26. Caselli M, Zullo A, Maconi G, Parente F, Alvisi V, Casetti T, Sorrentino D, Gasbarrini G. "Cervia II Working Group Report 2006": guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy. Dig Liver Dis 2007 39 : 782 9.
27. Chey WD, Wong BC. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 2007 102 : 1 18.
28. Klupinska G, Poplawski T, Drzewoski J, Harasiuk A, Reiter RJ, Blasiak J, Chojnacki J. Therapeutic effect of melatonin in patients with functional dyspepsia. J Clin Gastroenterol 2007 41 : 270 4.
29. Jin X, Li YM. Systematic review and meta-analysis from Chinese literature: the association between Helicobacter pylori eradication and improvement of functional dyspepsia. Helicobacter 2007 12 : 541 6.
30. de Leest HT, Steen KS, Lems WF, et al. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial. Helicobacter 2007 12 : 477 85.
31. Chan FK, Wong VW, Suen BY, et al. Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial. Lancet 2007 369 : 1621 6.
32. Li GQ, Xia HH, Chen MH, et al. Effects of aspirin on the development of Helicobacter pylori-induced gastric inflammation and heterotopic proliferative glands in Mongolian gerbils. Helicobacter 2008 13 : 20 9.